CION Ameerpet
Childhood Cancer Types — Parent’s Guide
Nasopharyngeal carcinoma in children — what every parent needs to know
Medically reviewed by Dr. C. Raghavendra Reddy, DM (Medical Oncology, Gold Medal) · Last reviewed June 2026
If your child has been told they may have nasopharyngeal carcinoma — also called NPC, or nose throat cancer — you deserve a clear and honest explanation of what this means. NPC is a cancer that starts in the lining of the nasopharynx, the part of the throat directly behind the nose. It is one of the less common childhood cancers, but it does occur in children and teenagers, and it is highly treatable when identified and managed by a specialist team. This page explains what childhood NPC is, what symptoms to watch for, how it is diagnosed, and what treatment involves, written for parents in plain language.
- Tumor board for every child — not one doctor’s opinion; a full multidisciplinary team reviews each case before any treatment begins
- 45-minute consultations — your questions are heard fully; no rushed decisions about your child’s treatment plan
- Free first consultation — paediatric oncology assessment at no charge for first-time patients
- Transparent costs — a written treatment plan and cost breakdown before anything begins
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding the diagnosis
What is nasopharyngeal carcinoma in children?
Nasopharyngeal carcinoma (NPC) is a cancer that starts in the epithelial lining of the nasopharynx — the air-filled space at the very top of the throat, sitting directly behind the nose and above the soft palate. The nasopharynx connects the nasal passages to the back of the throat and contains the openings of the Eustachian tubes, which regulate pressure in the ears. Because this area is completely hidden from view and not easily examined without a specialist instrument, tumours growing here can reach a significant size before a parent or child notices anything clearly wrong.
NPC is classified by the World Health Organization into three histological subtypes — keratinising squamous cell carcinoma (Type 1), non-keratinising differentiated carcinoma (Type 2), and non-keratinising undifferentiated carcinoma (Type 3). In children, Type 3 is by far the most common, representing the large majority of childhood cases. The undifferentiated subtype is strongly associated with the Epstein-Barr virus (EBV), and EBV markers are almost always detectable in tumour tissue and blood.
In the context of all childhood cancers, NPC is uncommon. However, it is one of the more frequent head and neck malignancies in adolescents, with most cases in children presenting between the ages of 10 and 19. It is more common in certain geographic regions and populations, including parts of North Africa and Southeast Asia; children with family members from these backgrounds may carry a modestly higher predisposition. The cancer is not caused by anything the child or family did, and the EBV-related genetic events that give rise to the tumour occur by chance in a susceptible individual.
One distinctive feature of childhood NPC — important for diagnosis — is that the tumour spreads early to regional lymph nodes in the neck in the majority of cases. This means a child very often presents with a lump in the neck as the first visible sign rather than with obvious nasal symptoms. The nasopharyngeal primary tumour may be small at diagnosis while the neck lymph node involvement is already significant. Understanding this pattern is why the diagnosis must always include direct examination of the nasopharynx and a biopsy, not just observation of the neck lump alone.
Signs and presentations
How NPC appears in children and teenagers — what parents notice first
Because the nasopharynx is a hidden cavity, NPC in children rarely announces itself dramatically at first. The signs can be subtle and are frequently attributed to more common causes. Understanding the patterns below can help a parent recognise when a symptom deserves specialist evaluation rather than watchful waiting.
Most common first sign
Neck lump — painless and persistent
The single most common reason a child with NPC is brought to a doctor is a lump in the neck, most often in the upper or posterior triangle of the neck. This represents spread to lymph nodes. The lump is usually painless, firm, and does not shrink over four to six weeks the way an infection-related swollen gland typically does. A lump that persists beyond four weeks without a clear infectious cause — especially in the upper neck — warrants prompt specialist review and should never be observed indefinitely without investigation.
- Painless, firm lymph node enlargement in the upper neck
- Does not resolve with a course of antibiotics
- May be bilateral (both sides) as disease progresses
Nasal symptoms
Blocked nose and blood-tinged discharge
As the tumour grows within the nasopharynx, it can partially or fully obstruct nasal airflow on one or both sides, causing a persistent blocked-nose sensation that does not respond to the usual treatments for rhinitis or sinusitis. Blood-tinged nasal discharge, nosebleeds that recur without clear cause (such as trauma or dry weather), or the sensation of blood at the back of the throat are important warning signs. A child or teenager who repeatedly spits blood-stained mucus from the back of the nose or throat needs prompt ENT evaluation.
- One-sided nasal blockage not explained by allergy or infection
- Recurrent nosebleeds without a trauma trigger
- Blood-tinged post-nasal discharge
Ear symptoms
Muffled hearing and ear fullness on one side
The Eustachian tube opening sits in the wall of the nasopharynx. When a tumour grows near this opening, it can block Eustachian tube function, causing a sensation of fullness or pressure in one ear, muffled or reduced hearing, or the sensation of fluid behind the eardrum (serous otitis media). In a teenager, this may be dismissed as a blocked ear or attributed to swimming or a cold. Any persistent one-sided hearing change lasting more than four weeks without an obvious cause deserves ENT assessment, including nasopharyngeal examination.
- Unilateral (one-sided) muffled hearing
- Sense of pressure or fullness in one ear
- Serous otitis media not improving with standard treatment
Advanced presentation
Headache, facial pain, or cranial nerve signs
In a small proportion of children, the tumour invades through the base of the skull into adjacent structures before the diagnosis is made. This can cause persistent headache, facial pain or numbness, double vision, drooping of an eyelid, or difficulty moving the eye if cranial nerves are involved. These symptoms represent a more advanced local disease and underline why prompt diagnostic workup is important whenever an unexplained neck lump or persistent nasal symptom is identified in a child or teenager. Headache alone is rarely caused by NPC, but headache combined with neck lump or nasal symptoms warrants investigation.
- Persistent headache not explained by other causes
- Facial numbness or pain along the cheekbone or jaw
- Double vision or eye movement difficulty
These patterns do not confirm NPC in isolation — each symptom has many common explanations. Their significance is in combination and persistence. If you are concerned, speak to a doctor promptly. — Explore the pediatric cancer hub · Child with a painless neck lump
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a second opinion from a full tumour board
Every child at CION gets a 45-minute consultation. No rushed decisions. No unnecessary tests. Decisions for healing, not billing.
Diagnosis & staging
How nasopharyngeal cancer in children is diagnosed — step by step
Reaching the correct diagnosis requires a structured sequence of investigations, each providing a different piece of information. The steps below reflect the standard diagnostic approach; your child’s team may sequence them slightly differently based on what findings emerge.
Clinical examination and history
The diagnostic journey starts with a careful clinical history and physical examination. The doctor asks about the duration and character of the neck lump, nasal symptoms, hearing changes, headache, and any weight loss or fatigue. The neck is examined methodically to assess how many lymph nodes are enlarged, their size, their consistency (hard vs. soft vs. matted), and whether they are fixed to surrounding structures. Both ears are examined. This examination guides which investigations to prioritise and in what order. In a child, the history of how symptoms have evolved over time is particularly valuable.
Nasopharyngoscopy — direct visualisation of the tumour site
An ear, nose, and throat (ENT) specialist uses a thin, flexible nasopharyngoscope — a lit instrument passed gently through the nostril — to directly examine the nasopharynx. This allows the doctor to see the tumour, assess its size and location within the cavity, and identify which structures are involved. In younger or anxious children, this may be performed under light sedation. The information from nasopharyngoscopy determines where to take the biopsy. If no obvious mass is visible but suspicion remains high, additional imaging is obtained before proceeding.
Biopsy — confirming the diagnosis
A small tissue sample (biopsy) is taken from the suspicious area in the nasopharynx. This sample is examined under a microscope by a pathologist, who confirms whether cancer is present and identifies the tumour type. In childhood NPC, the pathologist typically identifies the undifferentiated (WHO Type 3) pattern and may perform additional immunohistochemistry to confirm EBV-related markers within the tumour cells. In some situations, if access to the primary site is technically difficult, a biopsy of an enlarged neck lymph node may be done instead. Molecular confirmation is standard before any treatment is planned.
MRI of the head and neck — defining the tumour precisely
MRI with contrast is the imaging study of choice for the primary nasopharyngeal tumour. It defines the exact size and extent of the tumour within the nasopharynx, shows whether the tumour has grown through the base of the skull, identifies which neck lymph nodes are involved and their relationship to surrounding structures, and provides information needed for radiation treatment planning. Because the nasopharynx sits close to the base of the skull and adjacent to critical nerves and blood vessels, precise MRI assessment is essential before treatment can be designed. MRI is preferred over CT for soft-tissue detail, though a CT scan may be used alongside MRI in certain situations.
Staging scans — looking for spread beyond the head and neck
To determine whether NPC has spread to distant sites, the team uses imaging of the whole body. A CT scan of the chest and abdomen is commonly performed. A PET-CT scan is increasingly used in adolescents and children when available, because it is highly sensitive for detecting spread to lymph nodes, bone, liver, or lung in a single examination. A bone scan may be used if PET-CT is not available. Together, these staging investigations allow the team to classify the disease using the standard TNM staging system, which in turn guides the treatment plan — particularly the extent of the radiation field and the intensity of chemotherapy.
Blood tests — EBV DNA and baseline bloods
Blood tests at diagnosis include a full blood count, liver and kidney function tests, and measurement of EBV DNA levels in the plasma. EBV DNA is a tumour-derived marker that is elevated in most children with NPC at diagnosis. The pre-treatment level provides a baseline; subsequent measurements during and after treatment reflect how the tumour is responding. If EBV DNA does not fall appropriately with treatment, or rises again after treatment ends, this prompts earlier re-staging. All baseline results are reviewed by the multidisciplinary tumour board together before a treatment plan is finalised.
Has your child been referred for a nasopharyngeal workup?
Our paediatric oncology team can review scans and reports, clarify the findings, and help you understand the next step. Free for first-time patients.
Treatment
How nasopharyngeal carcinoma in children is treated
Treatment for childhood NPC is multimodal — meaning more than one type of treatment is used together. The exact sequence depends on the stage at diagnosis and is planned by the full tumour board before anything begins. Below are the main treatment components your child’s team will discuss.
Induction chemotherapy
In many childhood NPC protocols, chemotherapy is given first — before radiation — to shrink the primary tumour and the neck lymph nodes, and to treat any cells that may have spread beyond the visible disease. This “induction” phase typically runs for two to three cycles over six to nine weeks. The response is then assessed by imaging and EBV DNA levels before the next stage of treatment is planned. Induction chemotherapy helps the team understand how sensitive the tumour is to treatment before radiation begins.
Concurrent chemoradiation
The central component of childhood NPC treatment is radiation therapy to the nasopharynx and the neck lymph node regions, given at the same time as chemotherapy (“concurrent” chemoradiation). Combining chemotherapy with radiation enhances the tumour-killing effect of the radiation. Modern radiation is delivered using intensity-modulated radiotherapy (IMRT), a highly precise technique that shapes the radiation dose around the tumour while minimising the dose received by surrounding structures such as the salivary glands, inner ear, and spinal cord — which is particularly important in a growing child.
Adjuvant chemotherapy
After the concurrent chemoradiation phase is complete, additional cycles of chemotherapy may be given as “adjuvant” treatment — to address any remaining microscopic disease and reduce the risk of relapse. Whether adjuvant chemotherapy is used, and for how many cycles, depends on the stage of disease, the response seen during induction and concurrent phases, and the specific protocol followed by the treating team. Not all children require adjuvant chemotherapy; this is an individualised decision made by the tumour board.
Long-term follow-up and late-effects monitoring
After treatment ends, structured follow-up is essential in children because late effects of radiation to the head and neck can emerge months or years later. At CION, long-term monitoring includes regular clinical examination, EBV DNA levels in blood, imaging at planned intervals, thyroid function tests (as the thyroid may receive radiation if the lower neck is in the treatment field), hearing assessments, dental reviews, and endocrine evaluation if relevant. This coordinated approach ensures that any late effect is identified and managed early, supporting the child’s long-term health and development.
The specific treatment plan for your child will be presented by the multidisciplinary tumour board after reviewing all biopsy, imaging, and staging results. CION’s team includes medical, surgical, and radiation oncologists who together carry out a detailed 45-minute discussion with families before any treatment begins.
We walk this journey with you
Your child’s care begins with a conversation, not a bill
Our first consultation is free. You get a 45-minute session with a specialist, clear answers, and a written plan — with no pressure to start treatment immediately.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your questions about nasopharyngeal carcinoma in children — answered
What is nasopharyngeal carcinoma and why does it affect children?
Nasopharyngeal carcinoma (NPC) is a cancer that starts in the lining of the nasopharynx — the upper part of the throat that sits directly behind the nose and connects to the back of the nasal passages. Unlike many adult head-and-neck cancers, NPC occurs in children and teenagers more frequently than is often recognised. The reason it can affect younger people is linked to a combination of factors: the Epstein-Barr virus (EBV) plays a well-established role in most childhood NPC cases, and certain genetic backgrounds appear to confer a higher susceptibility. The tumour arises from the epithelial cells lining the nasopharynx. Because the nasopharynx is a hidden space at the back of the nose, the tumour can grow silently for weeks to months before producing noticeable symptoms, which is why the diagnosis in children is sometimes delayed.
What are the warning signs of NPC in a child or teenager?
The most common early sign of nasopharyngeal carcinoma in children is a painless lump in the neck — usually in the upper part of the neck — caused by lymph node enlargement. Because this can look and feel like a simple swollen gland, it is often initially attributed to infection. Other warning signs include persistent nasal blockage on one side, blood-tinged nasal discharge or nosebleeds that recur without a clear cause, a sensation of fullness or muffled hearing in one ear (because the tumour can block the Eustachian tube opening), and a change in the quality of the voice or difficulty swallowing if the tumour grows. Headache and facial pain or numbness can develop if the tumour invades nearby structures. Any combination of these signs lasting more than two to three weeks in a child or teenager warrants prompt medical evaluation.
How is nasopharyngeal carcinoma in children diagnosed?
Diagnosing childhood NPC begins with a careful clinical examination, including examination of the neck for enlarged lymph nodes. An ear, nose, and throat (ENT) specialist performs a nasopharyngoscopy — a thin flexible scope passed through the nostril to directly visualise the nasopharynx and identify any growth. If a suspicious area is seen, a biopsy (a small tissue sample) is taken from the nasopharynx and sent to a pathologist for analysis. The pathology report confirms whether the tissue is malignant and identifies the tumour type. MRI of the head and neck with contrast is the preferred imaging study to define the exact tumour boundaries and assess nearby structures. A CT scan of the chest and a PET-CT or bone scan may be used to look for spread to lymph nodes, lungs, or bone. Blood tests for Epstein-Barr virus (EBV) antibodies and EBV DNA levels are usually included, both for diagnosis and to monitor response to treatment over time.
Is the Epstein-Barr virus (EBV) related to NPC in children?
Yes. The Epstein-Barr virus (EBV) — the same virus that causes glandular fever (infectious mononucleosis) — is closely associated with the majority of childhood nasopharyngeal carcinoma cases. EBV DNA and proteins can be detected in the tumour cells, and blood levels of EBV antibodies and EBV DNA are elevated in most children with NPC. This does not mean that every child who has had EBV infection will develop NPC; the virus is extremely widespread in the population and almost all adults have been exposed to it. NPC is rare, and other factors — including individual genetic susceptibility — are needed alongside EBV for the tumour to develop. EBV DNA levels in the blood are nonetheless useful as a marker to monitor during and after treatment: levels that remain elevated or rise again after treatment can be an early sign of tumour activity.
What does treatment for childhood NPC involve?
Treatment for nasopharyngeal carcinoma in children is led by a multidisciplinary team and is different from the surgery-first approach used for many other head-and-neck cancers. The primary treatment is radiation therapy directed precisely at the nasopharynx and the neck lymph node regions, usually combined with chemotherapy given either before radiation (induction chemotherapy), alongside it (concurrent chemotherapy), or both. Surgery to the primary nasopharyngeal tumour is rarely used as initial treatment because the anatomy makes surgical access difficult and the tumour generally responds well to radiation combined with chemotherapy. Enlarged lymph nodes in the neck may sometimes be addressed surgically if they do not fully respond to chemoradiation. The specific protocol — which chemotherapy agents, timing, and radiation dose and field — is planned carefully for each child by the tumour board, balancing treatment effectiveness against the risk of long-term effects on a growing child. At CION, every child’s treatment plan is discussed by the full tumour board before a single step begins.
What are the long-term effects of NPC treatment in children?
Because children are still developing physically, radiation therapy to the head and neck region can have long-term effects that do not appear immediately. These can include dryness of the mouth (from salivary gland involvement in the radiation field), dental problems, changes to hearing (if the inner ear receives a significant radiation dose), effects on thyroid function if the lower neck is treated, and in some cases effects on facial bone growth in younger children. Modern radiation techniques such as intensity-modulated radiotherapy (IMRT) are designed to shape the radiation dose precisely around the tumour while reducing dose to surrounding healthy structures. Long-term follow-up by a multidisciplinary team — including oncologists, endocrinologists, audiologists, and dental specialists as needed — is therefore an important part of care after treatment. CION provides coordinated long-term monitoring so that late effects are identified and managed early.
Pediatric Cancer A–Z
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.